Valence Labs Research
Tissue Repair Research Blend
KLOW is a four-component research blend combining GHK-Cu, BPC-157, TB-500, and KPV. The blend brings together compounds individually investigated across tissue-repair, extracellular-matrix, cell-migration, angiogenesis, and inflammatory-response research.
Because KLOW is a combination research product, evidence for the individual components should not be presented as proof that the combined formulation produces the same effects.
The individual components of KLOW have been studied in different experimental models involving tissue repair and remodeling.
GHK-Cu research includes fibroblast activity, collagen synthesis, and extracellular-matrix biology.
Thymosin beta-4 research has investigated endothelial cell migration, angiogenesis, and wound-repair biology. BPC-157 has also been investigated in preclinical repair models involving angiogenic signaling.
KPV has been studied in cellular and animal inflammatory models, including research involving inflammatory signaling pathways.
The blend provides a research format for examining several repair- and inflammation-related pathways together. Published clinical evidence for this exact combination is not currently available.
The evidence maturity differs significantly between the four components.
GHK-Cu has laboratory and animal research involving collagen and extracellular matrix biology.
BPC-157 has extensive preclinical literature but very limited human research.
Thymosin beta-4 has substantial preclinical repair research and some human clinical research in wound-healing contexts.
KPV research is primarily cellular and animal-based.
This page summarizes research on the individual components. It does not describe a clinical trial of the KLOW combination itself.
Catalog details for this product.
99.63%
Purity
Passed full QC panel
Klow Blend
80mg
Please confirm you are 21 years of age or older to enter.
By entering, you confirm that you meet our minimum age requirement.